Michael Brian Bell - 15 Jun 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell
Issuer symbol
GH
Transactions as of
15 Jun 2024
Net transactions value
-$99,904
Form type
4
Filing time
17 Jun 2024, 18:37:34 UTC
Previous filing
18 Mar 2024
Next filing
16 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +1,233 +9.9% $0.000000 13,686 15 Jun 2024 Direct
transaction GH Common Stock Options Exercise $0 +8,034 +59% $0.000000 21,720 15 Jun 2024 Direct
transaction GH Common Stock Tax liability $99,904 -3,307 -15% $30.21 18,413 15 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -1,233 -12% $0.000000 8,631 15 Jun 2024 Common Stock 1,233 $0.000000 Direct F2, F3
transaction GH Restricted Stock Units Options Exercise $0 -8,034 -33% $0.000000 16,312 15 Jun 2024 Common Stock 8,034 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3 Not applicable for Restricted Stock Units.
F4 This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.